| scholarly article | Q13442814 |
| P50 | author | J Paul Taylor | Q55711783 |
| Björn Oskarsson | Q59878166 | ||
| Conrad C Weihl | Q114404424 | ||
| P2093 | author name string | Michael Benatar | |
| Joanne Wuu | |||
| Heather Katzen | |||
| Julie Steele | |||
| Catalina Fernandez | |||
| P2860 | cites work | Valosin-containing protein mutation and Parkinson's disease. | Q53227955 |
| Clinical studies in familial VCP myopathy associated with Paget disease of bone and frontotemporal dementia. | Q53292162 | ||
| Late-onset autosomal dominant limb girdle muscular dystrophy and Paget's disease of bone unlinked to the VCP gene locus | Q55880075 | ||
| A new familial disorder of combined lower motor neuron degeneration and skeletal disorganization | Q57462583 | ||
| Inclusion body myopathy and Paget disease is linked to a novel mutation in the VCP gene | Q58050234 | ||
| Inclusion body myopathy with Paget disease and frontotemporal dementia (IBMPFD): clinical features including sphincter disturbance in a large pedigree | Q64445119 | ||
| Clinical and molecular studies in a unique family with autosomal dominant limb-girdle muscular dystrophy and Paget disease of bone | Q73625727 | ||
| ALS patients with SOD1 mutations in Switzerland show very diverse phenotypes and extremely long survival | Q84434639 | ||
| Prolonged survival in motor neuron disease: a descriptive study of the King's database 1990-2002 | Q22306532 | ||
| Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS | Q24629495 | ||
| Exome sequencing reveals VCP mutations as a cause of familial ALS | Q24631513 | ||
| TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis | Q28270779 | ||
| Cell-free formation of RNA granules: low complexity sequence domains form dynamic fibers within hydrogels | Q29614781 | ||
| TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis | Q29616311 | ||
| El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis | Q29619074 | ||
| Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein | Q29619232 | ||
| Mutational analysis of the VCP gene in Parkinson's disease | Q35566788 | ||
| Phenotypic variability in three families with valosin-containing protein mutation. | Q37072776 | ||
| TDP-43 A315T mutation in familial motor neuron disease | Q37354490 | ||
| Valosin-containing protein disease: inclusion body myopathy with Paget's disease of the bone and fronto-temporal dementia | Q37452177 | ||
| ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration | Q37593829 | ||
| RNA-binding proteins with prion-like domains in ALS and FTLD-U. | Q37918720 | ||
| Cell-free formation of RNA granules: bound RNAs identify features and components of cellular assemblies. | Q39349822 | ||
| TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia | Q41667459 | ||
| Two Australian families with inclusion-body myopathy, Paget's disease of bone and frontotemporal dementia: novel clinical and genetic findings | Q43119772 | ||
| Characterization of the Asian myopathy patients with VCP mutations | Q43488914 | ||
| Heterogeneity in familial dominant Paget disease of bone and muscular dystrophy | Q43916486 | ||
| A novel mutation in the VCP gene (G157R) in a German family with inclusion-body myopathy with Paget disease of bone and frontotemporal dementia | Q46126082 | ||
| TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations | Q48284829 | ||
| Hereditary spastic paraplegia caused by a mutation in the VCP gene | Q48370935 | ||
| Pathological consequences of VCP mutations on human striated muscle | Q48418017 | ||
| Valosin-containing protein gene mutations: clinical and neuropathologic features | Q48491139 | ||
| P433 | issue | 20 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | amyotrophic lateral sclerosis | Q206901 |
| multisystem proteinopathy | Q17126319 | ||
| P1104 | number of pages | 7 | |
| P304 | page(s) | 1874-1880 | |
| P577 | publication date | 2013-05-01 | |
| P1433 | published in | Neurology | Q1161692 |
| P1476 | title | Motor neuron involvement in multisystem proteinopathy: implications for ALS | |
| P478 | volume | 80 |
| Q42062922 | A case of familial ALS due to multi-system proteinopathy 1 and Huntington disease |
| Q53050086 | A novel VCP mutation underlies scapuloperoneal muscular dystrophy and dropped head syndrome featuring lobulated fibers. |
| Q64060839 | Aberrant Phase Transitions: Side Effects and Novel Therapeutic Strategies in Human Disease |
| Q46130574 | Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria. |
| Q50350613 | Biology and Pathobiology of TDP-43 and Emergent Therapeutic Strategies. |
| Q38635213 | Clinical spectrum of valosin containing protein (VCP)-opathy |
| Q37599978 | Disease mutations in the prion-like domains of hnRNPA1 and hnRNPA2/B1 introduce potent steric zippers that drive excess RNP granule assembly. |
| Q35018480 | Exercise training reverses skeletal muscle atrophy in an experimental model of VCP disease |
| Q54158931 | Familial Amyotrophic Lateral Sclerosis. |
| Q38260359 | Genetic causes of amyotrophic lateral sclerosis: new genetic analysis methodologies entailing new opportunities and challenges |
| Q38814847 | Genetics of Frontotemporal Lobar Degeneration: From the Bench to the Clinic |
| Q46046794 | Genotype-phenotype study in patients with VCP valosin-containing protein mutations associated with multisystem proteinopathy. |
| Q34979278 | Immunoreactivity of valosin-containing protein in sporadic amyotrophic lateral sclerosis and in a case of its novel mutant |
| Q36733879 | Isolated inclusion body myopathy caused by a multisystem proteinopathy-linked hnRNPA1 mutation |
| Q52885717 | Late-onset distal myopathy of the upper limbs due to P.Ile151Val mutation in the valosin-containing protein. |
| Q39413091 | Motoneuron Disease: Basic Science |
| Q33894661 | Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophy |
| Q28080241 | Mutations in the Human AAA+ Chaperone p97 and Related Diseases |
| Q38701291 | New ALS-Related Genes Expand the Spectrum Paradigm of Amyotrophic Lateral Sclerosis |
| Q88250882 | New Developments in the Genetics of Inclusion Body Myositis |
| Q38170010 | New insight into neurodegeneration: the role of proteomics |
| Q26782984 | Phenotypic Heterogeneity of Monogenic Frontotemporal Dementia |
| Q38838008 | Presymptomatic ALS genetic counseling and testing: Experience and recommendations |
| Q33653996 | Protein Quality Control and the Amyotrophic Lateral Sclerosis/Frontotemporal Dementia Continuum |
| Q39227676 | RNA-binding proteins with prion-like domains in health and disease |
| Q28119072 | Rare Manifestation of a c.290 C>T, p.Gly97Glu VCP Mutation |
| Q46958756 | The Genetics of Monogenic Frontotemporal Dementia |
| Q34178673 | The VCP/p97 system at a glance: connecting cellular function to disease pathogenesis. |
| Q38825197 | The clinical spectrum of sporadic and familial forms of frontotemporal dementia. |
| Q38778723 | The frontotemporal dementia-motor neuron disease continuum |
| Q39505690 | Tongue atrophy and fasciculations in transthyretin familial amyloid neuropathy: An ALS mimicker |
| Q26764950 | Toward precision medicine in amyotrophic lateral sclerosis |
Search more.